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Abstract
Background: Norepinephrine (NE) and epinephrine (EPI) 
levels are higher in cord arterial blood relative to venous 
blood, consistent with active mechanisms of placental-
maternal clearance. There are no contemporary studies 
of cord arteriovenous blood levels of sulfated and non-
sulfated catechols.
Aim: To assess the arteriovenous differences in cord blood 
levels of dopamine (DA), the sulfated catecholamines and 
their sulfated and non-sulfated metabolites. To correlate 
levels of oxygen, H+/CO2, and glucose with cord catecho-
lamine levels.
Methods: Fifty-seven term infants, delivered by  elective 
cesarean section, were recruited. Cord arterial and 
venous blood was sampled; levels of glucose, lactate, 
blood gases, six catechols and their sulfated conjugates 
were measured.
Results: With one exception (DOPA sulfate), mean cord 
arterial levels of sulfated and non-sulfated catechols were 
significantly higher than venous levels. Arterial lactate 
and glucose levels were independently associated with 
NE levels, but only lactate was associated with levels of 
EPI and DA.
Conclusion: This study establishes that in vivo metabolic 
parameters of hypoxia, respiratory and metabolic acido-
sis are associated with catecholamine levels, a key rela-
tionship for perinatal adaptation and homeostasis, and 
findings that are consistent with in vitro studies of the 
regulators of catecholamine secretion.
Keywords: catecholamines; cesarean section; cord blood; 
glucose homeostasis.
Introduction
Plasma catecholamine levels rise three-to-tenfold within 
minutes of delivery [1]. The surge is induced by labor, 
which is why infants delivered vaginally have considerably 
higher cord artery and/or cord vein levels of norepineph-
rine (NE), and/or epinephrine (EPI), than those delivered 
by elective cesarean section [2–5].  Catecholamines are 
essential for postnatal adaptation and contribute to the 
regulation of cardiac output, blood pressure, thermogene-
sis, surfactant release, lung liquid production and absorp-
tion, as well as the regulation of blood glucose levels [6].
NE and EPI levels in cord artery, and to a lesser 
extent in cord vein, are substantially higher than those 
in (resting) adults, and maternal levels at delivery [7, 8]. 
Fetal ovine NE and EPI production and clearance rates 
are higher than in any other physiological condition [9], 
with placental transfer largely accounting for the very 
high intrauterine catecholamine clearance rates [10, 11]. 
The rapid increase in circulating catecholamine levels at 
birth is due, in part, to a significant decrease in clearance 
rates through removal of the placental contribution to 
whole body clearance [12]. Sulfoconjugation represents an 
important protective mechanism for inactivating catecho-
lamines, and so offers protection from the adverse effects 
of excess catecholamine levels [13]. In humans catechola-
mines circulate mainly (up to 99%) in the sulfoconjugated 
forms [14, 15].
The known molecular regulators of adrenomedullary 
catecholamine secretion in vitro are oxygen, H+/CO2, and 
glucose, which are proposed as important mediators in 
perinatal catecholamine regulation [16]. We predicted that 
levels of these regulators would show the strongest asso-
ciations, in regression analyses, with dopamine (DA), NE 
and EPI. That NE and EPI levels are higher in cord artery, 
than in cord vein, is already documented and consistent 
with active mechanisms of fetal-placental-maternal clear-
ance [5–7, 17, 18], but there are no contemporary studies of 
human cord arterial and venous blood levels of sulfated 
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and non-sulfated catechols. We hypothesized that there 
should also be differences between umbilical cord arterial 
and venous levels of DA, sulfated NE and EPI, as well as 
their sulfated and non-sulfated metabolites.
Methods
Participants and procedures
Mothers and infants were recruited in Ninewells Hospital and 
 Medical School, Dundee. All infants were born to women booked 
for elective cesarean section of a singleton, term infant (37+ gesta-
tional weeks). We aimed to recruit a consecutive sample of eligible 
pregnant women. Exclusion criteria were known Hepatitis B/C and 
HIV positivity. The study was approved by the Tayside Committee on 
Medical Research Ethics (Ref: 033/04).
The analytes were measured in umbilical venous and arterial 
cord blood. All blood samples were taken by DKMK immediately on 
delivery of the placenta. Approximately 20  mL of blood was taken 
from the umbilical vein and artery at the point of placental cord 
insertion (singly-clamped sample) using a 19 gauge butterfly nee-
dle (Abbott Ireland, Sligo, Republic of Ireland) and aliquoted within 
5 min of delivery into a variety of tubes, according to the analyte to 
be measured.
Analytes
Plasma glucose and lactate were measured using Roche Gluco-
quant kits and Cobas Lactate kits on Roche Modular Serum Work 
Area  Analysers (Roche Diagnostics, Mannheim, Germany). Blood 
gas analyses for pH, PCO2, PO2, cHCO3 (bicarbonate), and BE (base 
excess) used an AVL OMNI Modular System (Roche Diagnostics) in 
the labor ward, and was serviced by Biochemical Medicine as part 
of the UK accreditation scheme. Plasma for catechol estimations 
was prepared in lithium heparin tubes, immediately frozen, and 
stored at –80oC before air freighting to the laboratory of GE, Dres-
den, for analysis. Catechols (EPI, NE, DA, dihydroxyphenylalanine 
(DOPA), dihydroxyphenylglycol (DHPG), and dihydroxyphenylacetic 
acid (DOPAC)) and their sulfated conjugates (EPI sulfate, NE sulfate, 
DA sulfate, DOPA sulfate, DHPG sulfate, and DOPAC sulfate) were 
measured after extraction from plasma using an alumina extraction 
procedure and then separated and quantified by HPLC with electro-
chemical detection [19]. The inter-assay coefficient of variation was 
5.69% for DHPG, 2.76% for NE, 6.44% for DOPA, 10.27% for EPI, 5.47% 
for DOPAC, 11.75% for DHPG sulfate, 13.52% for NE sulfate, 13.62% 
for DOPA sulfate, 6.16% for EPI sulfate and 5.43% for DOPAC sulfate. 
Intra-assay coefficients of variation were 3.6% (DHPG), 2.9% (NE), 
3.1% (DOPA), 3.9% (EPI), 5.1% (DA) and 3.9% (DOPAC); intra-assay 
variation was not recorded for the sulfate conjugates.
Statistical analyses
Means and standard deviations (SD) and, as appropriate, medians 
and interquartile ranges, are reported for each analyte. Differences 
between means were quantified by the paired t-test. Correlation 
matrices were created of blood gas analytes, glucose, lactate and cat-
echols, using Spearman’s rho to account for the skewed distributions 
of some factors for all infants, and also sub-grouped into infants 
with glucose levels of  <  and  ≥ 2.6 mmol/L. Univariate general linear 
regression modeling was used to determine the contribution of arte-
rial levels of PO2, PCO2, pH, glucose and lactate on the active (arterial) 
catecholamines (DA, NE and EPI) contributing to the perinatal surge, 
using the enter method.
Results
Fifty-seven infants were recruited; mean gestation was 
37.6±0.6 weeks; 40% were female. All infants were deliv-
ered by elective cesarean section: 14 (25%) because of 
breech presentation or placenta praevia, 35 (61%) because 
of previous cesarean section or maternal wish and for 
eight (14%) the reason was unknown.
In cord arterial blood the mean glucose level was 
2.71  mmol/L, which was significantly lower than the 
level in cord venous blood of 3.07 mmol/L. Although the 
group as a whole were normoglycaemic, 14 infants had 
arterial plasma glucose levels   ≤  2.6  mmol/L, an addi-
tional three infants had both arterial and venous plasma 
glucose levels   ≤  2.6  mmol/L, and one further infant had 
venous plasma glucose levels   ≤  2.6  mmol/L. The mean 
lactate level was significantly lower in venous plasma 
(2.14  mmol/L) compared to the arterial sample (2.42 
mmol/L). Mean levels of pH and PO2 were significantly 
lower in arterial than venous plasma (respectively 7.31 and 
2.17 kPa vs. 7.34 and 2.77 kPa); whereas PCO2 was signifi-
cantly higher in arterial (6.87 kPa) than venous (6.25 kPa) 
plasma. Arterial and venous bicarbonate and base excess 
values slightly, but significantly, varied (Table 1).
In cord arterial plasma, levels of non-sulfated cat-
echols varied appreciably. The highest levels in order 
of  magnitude were those of NE (3494 pg/mL) and DOPA 
(3315  pg/mL), followed by DOPAC (2603 pg/mL), DHPG 
(1122 pg  mL) and EPI (637 pg/mL), with DA the lowest 
(35  pg/mL) (Figure 1). The pattern for levels of non- 
sulfated catechols in cord venous plasma was different, 
with that of NE showing the greatest reduction. DOPA had 
the highest circulating level (3073 pg/mL) followed by 
DOPAC (2370 pg/mL), DHPG (949 pg/mL), NE (647 pg/mL), 
EPI (58 pg/mL) and DA (19 pg/mL) (Figure 1). The propor-
tion of sulfated-catechols to non-sulfated catechols was 
variable; in cord arterial plasma the proportion ranged 
from DA sulfate ( > 99%) through intermediate figures for 
NE (40%) and DHPG sulfate (55%) to the lowest percent-
age DOPA sulfate (18%) (Table 2).
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Correlation analyses
The correlation matrices, shown separately for cord and 
venous blood, included 19 variables; only the strongly asso-
ciated variables (P < 0.0001) are shown (Tables  3  and  4). 
For the group of infants as a whole, levels of cord arterial 
plasma glucose were not associated with any of compo-
nent parts of the blood gas measurements, or levels of cat-
echols. Cord arterial plasma lactate levels were associated 
positively with NE and NE sulfate (Table  3) and venous 
Table 1: Arterial and venous levels of glucose, lactate and blood gases in umbilical cord plasma of term infants delivered by elective 
 cesarean section.
 
 
Arterial 
 
Venous  Matched 
pairs t-test
  Degree of 
freedom
  P-value
Mean 
Median
  Standard deviation 
Quartile range
Mean 
Median
  Standard deviation 
Quartile range
Glucose (mmol/L)  2.71  0.42  3.07  0.42  –8.881  45   < 0.0001
  2.70  2.40, 3.00  3.00  2.80, 3.30     
Lactate (mmol/L)   2.42  1.15  2.14  0.96  4.845  45   < 0.0001
  2.05  1.80, 2.60  2.00  1.60, 2.20     
pH   7.31  0.06  7.34  0.04  –7.797  49   < 0.0001
  7.32  7.27, 7.35  7.35  7.32, 7.37     
PO2 (kPa)   2.17  0.79  2.72  0.78  –3.724  49  0.001
  2.16  1.59, 2.71  2.72  2.15, 3.04     
PCO2 (kPa)   6.87  1.17  6.19  0.95  5.694  49   < 0.0001
  6.68  6.04, 7.63  6.27  5.78, 6.66     
cHCO3 (mmol/L)   25.04  1.81  24.63  1.52  2.209  49  0.03
  25.00  24.00, 26.60  24.95  23.58, 25.93     
BE (mmol/L)   –1.82  1.70  –1.51  1.51  –2.452  50  0.02
  –1.75  –2.83, –0.55  –1.20  –2.40, –0.40     
DOPA
DOPA
sulfate
DOPAC
sulfate
DOPAC
DOPAMINE
DOPAMINE
sulfate
DHPG
sulfate
MHPG
sulfate
MPHG
DHPG
3315 pg/mL artery
741 pg/mL
35.3 pg/mL 3494 pg/mL
647 pg/mL
637 pg/mL
58 pg/mL18.8 pg/mL
3391 pg/mL
2997 pg/mL
809 pg/mL
2603 pg/mL
1692 pg/mL 133 pg/mL
63 pg/mL1079 pg/mL 1122 pg/mL
949 pg/mL
NOR-EPINEPHRINE
sulfate
NOR-EPINEPHRINE EPINEPHRINE
EPINEPHRINE
sulfate METANEPHRINE
1303 pg/mL
1421 pg/mL
2370 pg/mL
HVA
VMA
676 pg/mL
711 pg/mL
3073 pg/mL vein
Figure 1: Mean levels of catechols, their precursor, and metabolites in venous and arterial cord blood.
(The top row of each pair of data shows arterial levels and the lower row shows venous levels.)
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lactate levels were correlated positively with NE, DHPG 
and DOPAC sulfate (Table 4). There were several asso-
ciations between the component parts of cord artery and 
venous blood gas measurements and levels of catechols, 
with pH and cHCO3 showing the strongest correlations 
(Tables 3 and 4). Unsurprisingly, there were many signifi-
cant associations between the various measurements of 
cord arterial plasma and cord venous plasma catechols 
(Tables 3 and 4).
The correlation matrix for the subgroup of infants 
whose cord glucose levels were  ≥ 2.6  mmol/L was very 
similar to those for the group as a whole (Table 5); although 
there were more significant correlations despite the smaller 
sample size. The matrix for the smaller subgroup of infants 
with low glucose levels ( < 2.6 mmol/L) showed few statisti-
cal associations although, and unlike the normoglycaemic 
group, there were significant negative correlations between 
glucose and DOPA, DA sulfate and DOPAC sulfate (Table 6).
Table 2: Arterial and venous levels of plasma catechols and their sulfated conjugates in cord plasma of term infants delivered by elective 
cesarean section.
 
 
Arterial 
 
Venous  P-value 
matched pairs 
Student t-test
  Arterio-
venous 
differencesaMean Median
  Standard deviation 
Quartile range
  n Mean 
Median
  Standard deviation 
Quartile range
  n
DOPA (pg/mL)   3315.0  ±590.1  56  3073.0  ±507.5  56   < 0.001  6.7%
  3344.0   2932.5, 3644.3    3079.0  2679.8, 3281.5     
DOPA sulfate (pg/mL)   741.2  ±291.3  51  711.3  ±229.2  51  0.525  –2.1%
  700.0  559.0, 842.0    685.0  585.0, 818.0     
DOPA sulfate (%)   17.9  ±4.4  51  18.6  ±4.4  51  0.401 
  17.6   15.3, 19.3    17.7  15.9, 21.2     
DA (pg/mL)   35.3  ±42.5  56  18.8  ±25.7  56   < 0.001  31.4%
  16.5  10.0, 49.3    9.0  7.0, 18.0     
DA sulfate (pg/mL)   3391.1  ±1562.6  51  2997.1  ±910.2  51  0.003  6.8%
  3128.0  2274.0, 3703.0    2920.0  2279.0, 3457.0     
DA sulfate (%)   98.9  ±1.5  51  99.3  ±1.2  51   < 0.001 
  99.5  98.7, 99.7    99.7  99.4, 99.8     
NE (pg/mL)   3493.5  ±3035.6  56  646.6  ±731.0  56   < 0.001  77.2%
  2234.0  1166.5, 5219.5    379.5  186.0, 737.3     
NE sulfate (pg/mL)   1691.8  ±1053.8  51  1079.1  ±400.2  51   < 0.001  27.4%
  1359.0  1001.0, 2048.0    959.0  803.0, 1358.0     
NE sulfate (%)   40.4  ±15.5  51  70.0  ±15.3  51   < 0.001 
  37.7  27.8, 48.4    73.5  61.9, 82.8     
EPI (pg/mL)   636.7  ±685.0  56  58.2  ±96.3  56   < 0.001  87.2%
  353.0  205.0, 812.5    27.5  11.3, 61.3     
EPI sulfate (pg/mL)   132.8  ±112.5  51  62.6  ±44.5  51   < 0.001  38.7%
  97.0  55.0, 178.0    51.0  31.0, 80.0     
EPI sulfate (%)   23.9  ±13.1  51  62.3  ±22.1  51   < 0.001 
  19.9  15.7, 29.0    64.5  45.5, 80.6     
DOPAC (pg/mL)   2603.3  ±765.2  56  2369.6  ±717.3  56   < 0.001  8.5%
  2513.5  2098.3, 2932.0    2239.0  1855.5, 2698.0     
DOPAC sulfate (pg/mL)  808.5  ±563.1  51  676.3  ±209.5  51  0.091  8.4%
  698.0  598.0, 866.0    627.0  535.0, 745.0     
DOPAC sulfate (%)   23.3  ±8.4  51  22.6  ±4.8  51  0.556 
  22.0  19.1, 25.7    23.1  18.2, 26.6     
DHPG (pg/mL)   1122.1  ±400.9  56  949.2  ±373.7  56   < 0.001  15.4%
  1042.0  891.3, 1279.0    881.0  737.0, 1051.8     
DHPG sulfate (pg/mL)   1420.8  ±544.8  51  1303.0  ±466.1  51  0.002  6.5%
  1367.0  959.0, 1774.0    1281.0  885.0, 1645.0     
DHPG sulfate (%)   55.3  ±7.9  51  57.6  ±7.8  51   < 0.001 
  54.2  49.7, 60.3    57.5  52.1, 62.6     
DA = dopamine, DHPG = dihydroxyphenylglycol, DOPA = dihydroxyphenylalanine, DOPAC = dihydroxyphenylacetic acid, EPI = epinephrine, 
NE = norepinephrine. Conversion factors to nmol/L multiply: EPI × 0.00546, NE × 0.00591, DHPG × 0.00588, DOPA × 0.00507, DA × 0.00653, 
DOPAC × 0.00595.
a((arterial-venous)/arterial)x100 (calculated for each infant).
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Table 3: Selected correlations between cord artery levels of glucose, lactate, blood gas components and catechols of term infants 
 delivered by elective cesarean section.a
Analyte   Cord arterial blood
Correlated with   Correlation coefficient ( ≥ 0.5)
rho   P-value   n
Glucose (mmol/L)     No significant correlations
Lactate (mmol/L)   NE pg/mL   +0.653    < 0.0001   46
  NE sulfate pg/mL   +0.541    < 0.0001   43
pH   PCO2 kPa   –0.899    < 0.0001   50
  PO2 kPa   +0.627    < 0.0001   50
  DHPG pg/mL   –0.528    < 0.0001   49
PCO2 (kPa)   PO2 kPa   –0.604    < 0.0001   50
  cHCO3 mmol/L   +0.633    < 0.0001   49
cHCO3 (mmol/L)   BE pg/mL   +0.696    < 0.0001   49
DA (pg/mL)   NE pg/mL   +0.527    < 0.0001   56
NE (pg/mL)   EPI pg/mL   +0.690    < 0.0001   56
  DHPG pg/mL   +0.516    < 0.0001   56
  NE sulfate pg/mL   +0.650    < 0.0001   51
EPI (pg/mL)   DHPG pg/mL   +0.572    < 0.0001   56
  EPI sulfate pg/mL   +0.810    < 0.0001   51
DHPG (pg/mL)   DOPAC pg/mL   +0.533    < 0.0001   56
  DHPG sulfate pg/mL   +0.546    < 0.0001   51
  DOPA sulfate pg/mL   +0.520    < 0.0001   51
DOPA (pg/mL)   DOPAC pg/mL   +0.525    < 0.0001   56
  DOPA sulfate pg/mL   +0.587    < 0.0001   51
DA sulfate (pg/mL)   NE sulfate pg/mL   +0.589    < 0.0001   51
  DOPA sulfate pg/mL   +0.555    < 0.0001   51
NE sulfate (pg/mL)   DOPA sulfate pg/mL   +0.629    < 0.0001   51
DA = dopamine, DHPG = dihydroxyphenylglycol, DOPA = dihydroxyphenylalanine, DOPAC = dihydroxyphenylacetic acid, EPI = epinephrine, 
NE = norepinephrine.
aThe full correlation matrix is available from the corresponding author; this table shows significant values with Bonferroni correction factor.
Table 4: Selected correlations between cord venous levels of glucose, lactate, blood gas components and catechols of term infants 
 delivered by elective cesarean section.a
Analyte   Cord arterial blood
Correlated with    Correlation coefficient ( ≥ 0.5)
rho   P-value   n
Glucose (mmol/L)     No significant correlations
Lactate (mmol/L)   NE pg/mL   +0.647    < 0.0001   45
  DHPG pg/mL   +0.528    < 0.0001   45
  DOPAC sulfate pg/mL   +0.521    < 0.0001   43
pH   PCO2 kPa   –0.784    < 0.0001   55
PCO2 (kPa)   cHCO3 mmol/L   +0.669    < 0.0001   54
cHCO3 (mmol/L)   BE mmol/L   +0.817    < 0.0001   54
NE (pg/mL)   EPI pg/mL   +0.645    < 0.0001   56
  DHPG pg/mL   +0.692    < 0.0001   56
  NE sulfate pg/mL   +0.518    < 0.0001   51
EPI (pg/mL)   DHPG pg/mL   +0.524    < 0.0001   56
DHPG (pg/mL)   DOPAC pg/mL   +0.515    < 0.0001   56
  DHPG sulfate pg/mL   +0.523    < 0.0001   51
DOPA (pg/mL)   DOPAC pg/mL   +0.563    < 0.0001   56
DOPA sulfate (pg/mL)  DOPAC sulfate pg/mL   +0.509    < 0.0001   51
DA = dopamine, DHPG = dihydroxyphenylglycol, DOPA = dihydroxyphenylalanine, DOPAC = dihydroxyphenylacetic acid, EPI = epinephrine, 
NE = norepinephrine.
aThe full correlation matrix is available from the corresponding author; this table shows significant values with Bonferroni correction factor.
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Arteriovenous differences
Mean cord arterial levels of glucose, pH and PO2 were 
significantly lower, and of PCO2 significantly higher than 
mean cord venous levels. There were no arteriovenous dif-
ferences in levels of lactate (Table 1).
There were highly significant arteriovenous differ-
ences in levels of all plasma catechols and their sulfated 
conjugates except DOPA sulfate and DOPAC sulfate 
(Table  2). Mean cord venous catechol levels were all 
significantly lower than those of cord arterial plasma 
levels. The smallest differences were for DOPA sulfate 
(–2%), DOPA (7%), DA sulfate (7%), DOPAC sulfate (8%) 
and DHPG sulfate (7%); the largest differences were 
observed for NE (77%) and EPI (87%). Moderate and 
variable arteriovenous differences were observed for DA 
Table 5: Selected correlations between cord artery levels of glucose, lactate, blood gas components and catechols of term infants with a 
cord glucose  ≥ 2.6 mmol/L at delivery.a
Analyte   Cord arterial blood
Correlated with    Correlation coefficient ( ≥ 0.5)
rho   P-value   N
Glucose (mmol/L)     No significant correlations
Lactate (mmol/L)   pH   –0.512   0.005   28
  BE pg/mL   –0.630    < 0.0001   28
  NE pg/mL   +0.630    < 0.0001   29
  DHPG pg/mL   +0.511   0.005   29
  NE sulfate pg/mL   +0.542   0.003   28
  DOPA sulfate pg/mL   +0.550   0.002   28
  DOPAC sulfate pg/mL   +0.524   0.004   28
pH   PCO2 kPa   –0.910    < 0.0001   28
  PO2 kPa   +0.543   0.003   28
  DOPA sulfate pg/mL   –0.603   0.001   27
PCO2 (kPa)   cHCO3 mmol/L   +0.565   0.002   28
  DOPAC pg/mL   +0.540   0.003   28
  DOPA sulfate pg/mL   +0.683    < 0.0001   27
  DOPAC sulfate pg/mL   +0.522   0.005   27
cHCO3 (mmol/L)   BE pg/mL   +0.644    < 0.0001   28
DA (pg/mL)   NE pg/mL   +0.503   0.005   29
NE (pg/mL)   EPI pg/mL   +0.662    < 0.0001   29
  DOPAC sulfate pg/mL   +0.544   0.003   28
EPI (pg/mL)   DHPG pg/mL   +0.695    < 0.0001   29
  DOPAC pg/mL   +0.504   0.005   29
  EPI sulfate pg/mL   +0.795    < 0.0001   28
  DHPG sulfate pg/mL   +0.596   0.001   28
  DOPA sulfate pg/mL   +0.647    < 0.0001   28
DHPG (pg/mL)   DOPA pg/mL   +0.629    < 0.0001   29
  DOPAC pg/mL   +0.599   0.001   29
  EPI sulfate pg/mL   +0.573   0.001   28
  DHPG sulfate pg/mL   +0.550   0.002   28
  DOPA sulfate pg/mL   +0.688    < 0.0001   28
  DOPAC sulfate pg/mL   +0.587   0.001   28
DOPA (pg/mL)   DOPAC pg/mL   +0.695    < 0.0001   29
  DOPA sulfate pg/mL   +0.718    < 0.0001   28
DOPAC (pg/mL)   DOPA sulfate pg/mL   +0.580   0.001   28
NE sulfate (pg/mL)   DOPA sulfate pg/mL   +0.590   0.001   28
EPI sulfate (pg/mL)   DOPA sulfate pg/ml   +0.576   0.001   28
DHPG sulfate (pg/mL)  DOPA sulfate pg/mL   +0.513   0.005   28
DOPA sulfate (pg/mL)   DOPAC sulfate pg/mL   +0.552   0.002   28
DA = dopamine, DHPG = dihydroxyphenylglycol, DOPA = dihydroxyphenylalanine, DOPAC = dihydroxyphenylacetic acid, EPI = epinephrine, 
NE = norepinephrine.
aThe full correlation matrix is available from the corresponding author.
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(31%), NE sulfate (27%), EPI sulfate (39%), and DHPG 
(15%) (Table 2).
Regression analyses
The regression analyses examined the relationship of the 
possible metabolic mediators (PO2, PCO2, glucose, and 
lactate) of adrenomedullary catecholamine  secretion to 
the cord artery levels of the active catecholamines (DA, 
NE, EPI). (Because PCO2 and pH were highly correlated 
(–0.899) only PCO2 was used in the regression  modeling.) 
Only (rising) lactate level was a significant predictor of DA 
level, accounting for 32.2% of the variation. Falling glucose 
and rising lactate levels were significant predictors of NE 
levels, accounting for 35% of the variation. Only rising 
lactate level was a significant predictor of EPI levels, 
accounting for 23.3% of the variation (Table 7).
Discussion
Increased catecholamine production or adrenomedullary 
release has been proposed as the reason for the postna-
tal surge in levels, responding to combinations of stimuli, 
such as compression of the fetal head, alternating hypoxia 
caused by uterine contractions, cooling of the infant, 
and manual handling at delivery [4, 6, 20, 21]. But there 
might be a further contributory factor, which is based on 
active placental metabolism, and/or maternal transfer 
Table 6: Selected significant correlations between cord artery levels of glucose, lactate, blood gas components and catechols of term 
infants with a cord glucose  < 2.6 mmol/L at delivery.a
Analyte   Cord arterial blood
Correlated with    Correlation coefficient ( ≥ 0.5)
rho   P-value   n
Glucose (mmol/L)   DOPA pg/mL   –0.503   0.040   17
  DA sulfate pg/mL   –0.522   0.046   15
  DOPAC sulfate pg/mL   –0.651   0.009   15
Lactate (mmol/L)   NE pg/mL   +0.636   0.006   17
  DA sulfate pg/mL   +0.702   0.004   15
  NE sulfate pg/mL   +0.556   0.028   15
  DOPA sulfate pg/mL   +0.610   0.016   15
pH   PCO2 kPa   –0.877    < 0.0001   14
  PO2 kPa   +0.710   0.004   14
  DHPG pg/mL   –0.626   0.017   14
PCO2 (kPa)   PO2 kPa   –0.754   0.002   14
  cHCO3 mmol/L   +0.802   0.001   14
PO2 (kPa)   cHCO3 mmol/L   –0.576   0.032   14
cHCO3 (mmol/L)   BE pg/mL   +0.889    < 0.0001   14
DA (pg/mL)   NE sulfate pg/mL   +0.543   0.037   14
NE (pg/mL)   EPI pg/mL   +0.623   0.008   14
  DA sulfate pg/mL   +0.525   0.044   14
  NE sulfate pg/mL   +0.868    < 0.0001   15
  DOPA sulfate pg/mL   +0.568   0.027   15
EPI (pg/mL)   EPI sulfate pg/mL   +0.757   0.001   15
DHPG (pg/mL)   DOPAC pg/mL   +0.490   0.046   17
  DHPG sulfate pg/mL   +0.654   0.008   15
DOPA (pg/mL)   DOPA sulfate pg/mL   +0.625   0.013   15
DOPAC (pg/mL)   DHPG sulfate pg/mL   +0.582   0.023   15
  DOPAC sulfate pg/mL   +0.518   0.048   15
DA sulfate (pg/mL)   NE sulfate pg/mL   +0.618   0.014   15
  DOPA sulfate pg/mL   +0.586   0.022   15
  DOPAC sulfate pg/mL   +0.697   0.004   15
NE sulfate (pg/mL)   DOPA sulfate pg/mL   +0.661   0.007   15
DA = dopamine, DHPG = dihydroxyphenylglycol, DOPA = dihydroxyphenylalanine, DOPAC = dihydroxyphenylacetic acid, EPI = epinephrine, 
NE = norepinephrine.
aThe full correlation matrix is available from the corresponding author.
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of catechols from fetal arterial blood, so creating an A–V 
 difference. At birth, the separation from placental metab-
olism/maternal transfer allows for an immediate post-
natal surge in infant catecholamine levels. This concept 
is supported by the presence of the relevant catabolic 
enzymes and transporters in the placenta and associated 
membranes [e.g. 12]. In addition, catecholamine levels are 
higher in the fetal umbilical artery relative to the umbilical 
vein (combined EPI, NE) [22], and singly for EPI, NE [7]. 
Our results contribute to this evidence for an A–V differ-
ence in catecholamine levels. But as far as we are aware, 
there are no comparable studies of human umbilical 
blood levels of non-sulfated and sulfated catechols, which 
we have already shown are very much higher in venous 
blood of postnatal preterm and term infants [23].
Dopamine is the main inotropic pharmacological 
agent used to support blood pressure in neonates, and 
it is likely that it has a similar function physiologically. 
DA within the brain regulates the proliferation of neuron 
progenitor cells [24], but the delineation of roles for cir-
culating DA in the fetus have, as yet, been limited to the 
regulation of pituitary prolactin secretion [25], and to the 
control of the development of cardiomyocytes, and renal 
tubular epithelial cells [26, 27].
Sulfation of hormones results in inactivation of 
biological activity, and is a particularly important 
mechanism in fetal life. For example, DA is sulfated by 
a specific sulfotransferase, SULT1A3, which in human 
postnatal liver is only 10% of the activity found in fetal 
liver, suggesting a programmed switch in SULT1A3 
expression [28], perhaps in response to the significant 
amounts of brain DA entering the systemic circulation, 
prior to maturation of the blood-brain barrier [29]. The 
human fetal adrenal gland secretes dehydroepiandros-
terone sulfate, and this hormone is reactivated in the 
placenta through removal of the sulfate moiety by sul-
fatase activity [30]. This process of reversible sulfation, 
which potentially allows hormonal targeting to cells 
expressing sulfatase activity, has also been described 
in thyroid hormones in the human fetus [28], but to our 
knowledge has not been explored for the catechola-
mines, and in particular DA.
Molecular regulators of carotid body and adre-
nomedullary catecholamine secretion are oxygen, H+/
CO2, and glucose, suggesting they are important meta-
bolic mediators in perinatal catecholamine regulation 
[16, 31]; if this is so, regression analyses should show 
that these regulators have the strongest associations with 
DA, NE and EPI. However, bivariate associations between 
levels of cord artery glucose and catecholamines were 
very weakly negative in the study group as a whole, and 
also in the subgroup of normoglycemic infants (glucose 
Table 7: Regression analyses of PO2, PCO2, glucose and lactate on the cord arterial catecholamine levels of DA, NE and EPI.
 
 
Unstandardized coefficients 
 
Standardized coefficients  t Statistic  P-value
B  Standard error Beta
Dopamine dependent variable         
 Independent variables          
  PCO2 (kPa)   0.094  6.034  0.003  0.016  0.988
  PO2 (kPa)   –10.759  8.008  –0.215  –1.343  0.187
  Glucose (mmol/L)   6.693  12.364  0.073  0.541  0.592
  Lactate (mmol/L)   17.506  5.407  0.531  3.238  0.003
Adjusted r2 32.2% residual standard deviation 31.92 residual df 37
Norepinephrine dependent variable
 Independent variables
  PCO2 (kPa)   227.119  392.590  0.108  0.579  0.566
  PO2 (kPa)   398.162  521.047  0.120  0.764  0.450
  Glucose (mmol/L)   –2029.683  804.468  –0.335  –2.523  0.016
  Lactate (mmol/L)   1130.466  351.806  0.516  3.213  0.003
Adjusted r2 35.0% residual standard deviation 2076.802 residual df 37
Epinephrine dependent variable
 Independent variables
  PCO2 (kPa)   13.066  100.296  0.026  0.130  0.897
  PO2 (kPa)   –158.628  133.113  –0.203  –1.192  0.241
  Glucose (mmol/L)   –168.807  205.519  –0.119  –0.821  0.417
  Lactate (mmol/L)   213.310  89.877  0.415  2.373  0.023
Adjusted r2 23.3% residual standard deviation 530.565 residual df 37
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levels  ≥ 2.6 mmol/L). However, most cord arterial bloods 
were normoglycaemic, not surprising, as the fetus ben-
efits from a positive maternal-placental glucose trans-
fer gradient, and the women were normoglycaemic, not 
in labor, and were delivered by cesarean section. In the 
small subgroup, with glucose levels  < 2.6 mmol/L, there 
were significant associations with rising levels of DOPAC 
sulfate, and to a lesser extent with DA sulfate, and DOPA, 
suggesting some activation of catechol metabolism. In 
our previous studies of infant postnatal glucose homeo-
stasis, it was only when hypoglycaemia was severe and 
prolonged, (which is not the case in this current subgroup 
with glucose levels  < 2.6 mmol/L), that there was an asso-
ciation of low blood glucose levels with increased EPI 
levels [23].
The non-stressed fetus is relatively hypoxic with 
a compensated respiratory acidosis, which remains 
even after placental perfusion. If placental perfusion 
is reduced, for example by uterine contractions, then 
the hypoxia and acidosis is compounded. Increases in 
fetal hypoxia, with decreases in cord arterial PO2 levels, 
are associated with increases in a number of catechols. 
That increasing H+ and PCO2 levels in cord arterial blood 
of non-stressed infants are significantly, and positively 
associated with many catechols levels, but especially 
and importantly with NE and EPI, supports the concept 
that they act as metabolic mediators in perinatal catecho-
lamine regulation.
In addition to oxygen, H+/CO2 and glucose, we also 
included lactate levels in the linear regression modeling of 
the potential influences on catechol metabolism, because 
lactate levels are related to the metabolic acidosis arising 
from the increasingly anaerobic metabolism of glucose as 
hypoxia develops. That lactate, rather than glucose levels, 
are such a strong predictor of NE, EPI and DA levels, is a 
key finding, particularly the highly significant correla-
tion of lactate to NE levels in both artery and vein, and to 
the immediately related products of NE metabolism (NE 
sulfate and DHPG). In contrast, in correlation analyses, 
there is no significant relationship between lactate levels 
and DA, or its immediate metabolites (DOPAC and DA 
sulfate), but that to NE and EPI is retained. It is not yet 
clear whether these associations are indicators of a direct 
regulatory effect of lactate on catecholamine secretion, 
such as exists for glucose; or whether it is a surrogate 
effect of pCO2/H+ on the carotid body and adrenomed-
ullary cells [16, 32]. Or indeed, whether it is a surrogate 
effect of reduced O2 on adrenomedullary cells, both of 
which (raised PCO2/H+ and reduced PO2), occur with rela-
tive hypoxia, and all of which are known to stimulate cat-
echolamine secretion [16]. A possible independent role 
for lactate in the catecholamine surge is supported by the 
regression analyses, which shows that levels of lactate, 
but not PCO2 or PO2 (or glucose consistently) are inde-
pendently associated with NE, EPI and DA levels in cord 
artery. A further consideration is that catecholamine infu-
sions in the experimental animal may generate lactate 
from the hepatic glucose released [33]. Lactate levels are 
higher in cord arterial blood than in the postnatal infant, 
although there is a transient increase in lactate levels in 
the immediate postnatal period, as circulatory perfusion 
improves into tissues vasoconstricted during delivery. 
In the early postnatal period, oxygen levels rise rapidly, 
with reductions in hydrogen ion, PCO2 and lactate levels, 
metabolic conditions conducive to reductions in catechol 
levels, and antagonistic to the circumstances that drive a 
postnatal catecholamine surge.
Maintenance of oxygen levels, acid-base balance, 
and energy supply are essential metabolic processes to 
be regulated by the fetus in utero, during labor, and into 
the postnatal period. Catecholamines have key regula-
tory roles in this transition, and as the homeostatic set-
points change from the relatively hypoxic, and mildly 
acidic environment of the fetus to that of relative post-
natal hyperoxia and acid-base neutrality, it is perhaps 
not surprising that the regulatory factors, which influ-
ence catechols levels, are also likely to change. The with-
drawal of placental catechol metabolism ensures higher 
postnatal catecholamine levels. But what cannot be 
answered, as yet, is the postnatal role of oxygen, H+/CO2, 
and glucose in the regulation of catecholamine levels, 
and as importantly, at what levels, and do they change 
after birth?
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